First Header Logo Second Header Logo

Amber Reeves-Daniel

Concepts (122)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Transplantation
18
2020
518
1.960
Why?
Tissue Donors
11
2018
199
1.340
Why?
Delayed Graft Function
4
2018
33
0.770
Why?
Graft Survival
13
2019
315
0.720
Why?
Living Donors
3
2020
63
0.630
Why?
Donor Selection
5
2020
33
0.550
Why?
Kidney Failure, Chronic
4
2016
541
0.550
Why?
Health Services Accessibility
2
2017
242
0.500
Why?
Insurance Coverage
1
2013
75
0.420
Why?
Tissue and Organ Procurement
6
2018
93
0.420
Why?
Acetanilides
1
2010
5
0.380
Why?
Ethnic Groups
1
2013
480
0.370
Why?
Tacrolimus
1
2010
64
0.360
Why?
Piperazines
1
2010
60
0.360
Why?
Complement C1q
1
2010
4
0.360
Why?
Glomerulosclerosis, Focal Segmental
1
2010
38
0.350
Why?
Enzyme Inhibitors
1
2010
176
0.350
Why?
Molecular Motor Proteins
1
2010
58
0.350
Why?
Myosin Heavy Chains
1
2010
89
0.340
Why?
Apolipoproteins
4
2016
200
0.330
Why?
Immunosuppressive Agents
1
2010
238
0.330
Why?
Diabetic Neuropathies
1
2008
24
0.320
Why?
Cyclohexanecarboxylic Acids
1
2008
21
0.320
Why?
Amines
1
2008
22
0.320
Why?
Lipoproteins, HDL
4
2016
253
0.320
Why?
Hearing Loss
1
2008
27
0.320
Why?
Anticonvulsants
1
2008
69
0.310
Why?
Follow-Up Studies
8
2019
2296
0.310
Why?
gamma-Aminobutyric Acid
1
2008
75
0.310
Why?
Pancreas Transplantation
3
2014
246
0.260
Why?
Renal Insufficiency, Chronic
2
2020
293
0.260
Why?
Female
17
2019
20126
0.250
Why?
Graft Rejection
3
2018
239
0.250
Why?
Caveolin 1
2
2015
13
0.240
Why?
Survival Rate
6
2018
894
0.240
Why?
African Americans
4
2017
1443
0.240
Why?
Middle Aged
15
2019
11949
0.230
Why?
Retrospective Studies
10
2019
3514
0.230
Why?
Humans
22
2020
32297
0.220
Why?
Genetic Testing
2
2020
99
0.210
Why?
Male
15
2019
19488
0.200
Why?
Adult
14
2019
9467
0.190
Why?
Kidney Diseases
2
2014
255
0.180
Why?
Prognosis
5
2018
1523
0.180
Why?
Cadaver
6
2018
163
0.170
Why?
Polymorphism, Single Nucleotide
2
2015
1092
0.160
Why?
Cold Ischemia
1
2018
7
0.160
Why?
Time Factors
4
2016
2181
0.150
Why?
C-Peptide
2
2014
29
0.150
Why?
Postoperative Complications
2
2020
788
0.140
Why?
African Continental Ancestry Group
2
2020
364
0.130
Why?
United States
4
2017
3983
0.130
Why?
Aged
7
2019
10398
0.130
Why?
Genetic Predisposition to Disease
3
2020
849
0.120
Why?
Tissue and Organ Harvesting
2
2020
38
0.120
Why?
Glomerular Filtration Rate
4
2018
309
0.120
Why?
Haplotypes
2
2015
224
0.120
Why?
Risk Factors
6
2018
3876
0.110
Why?
Incidence
1
2016
1207
0.110
Why?
Disease Progression
2
2014
618
0.100
Why?
Kidney Function Tests
3
2018
106
0.100
Why?
Aged, 80 and over
2
2017
4050
0.100
Why?
Young Adult
5
2019
2626
0.100
Why?
Diabetes Mellitus
1
2014
410
0.100
Why?
Genetic Variation
1
2012
247
0.090
Why?
Drug Interactions
1
2010
83
0.090
Why?
Perfusion
2
2008
72
0.090
Why?
Death, Sudden, Cardiac
1
2011
63
0.090
Why?
Nephrotic Syndrome
1
2010
13
0.090
Why?
Kidney Tubules
1
2010
28
0.090
Why?
Kidney Glomerulus
1
2010
31
0.090
Why?
Genotype
3
2017
742
0.090
Why?
Anuria
1
2008
3
0.080
Why?
Myoclonus
1
2008
2
0.080
Why?
Age Factors
3
2019
1204
0.080
Why?
Dose-Response Relationship, Drug
1
2010
675
0.080
Why?
Phenotype
3
2016
656
0.080
Why?
Extracorporeal Circulation
1
2008
13
0.080
Why?
Organ Preservation
1
2007
37
0.070
Why?
Nephrectomy
2
2020
126
0.070
Why?
Comorbidity
1
2008
572
0.070
Why?
Renal Dialysis
1
2008
282
0.070
Why?
Treatment Outcome
4
2016
3358
0.060
Why?
Hypertension
1
2011
972
0.060
Why?
Chi-Square Distribution
2
2016
302
0.060
Why?
Proportional Hazards Models
2
2016
759
0.060
Why?
Creatinine
2
2016
200
0.060
Why?
Multivariate Analysis
2
2016
696
0.050
Why?
Transplantation, Homologous
1
2020
151
0.040
Why?
Resource Allocation
1
2017
10
0.040
Why?
Survival Analysis
1
2019
491
0.040
Why?
Practice Guidelines as Topic
1
2020
410
0.040
Why?
Infant
1
2019
1076
0.030
Why?
Reoperation
1
2016
229
0.030
Why?
Mutation
1
2017
503
0.030
Why?
Preoperative Period
1
2014
35
0.030
Why?
Genetic Association Studies
1
2015
147
0.030
Why?
Child, Preschool
1
2019
1281
0.030
Why?
Odds Ratio
1
2016
480
0.030
Why?
Postoperative Period
1
2014
100
0.030
Why?
Registries
1
2016
300
0.030
Why?
Patient Selection
1
2014
289
0.030
Why?
Heredity
1
2012
13
0.030
Why?
Pedigree
1
2012
141
0.030
Why?
Child
1
2019
2472
0.030
Why?
Gene Frequency
1
2012
221
0.030
Why?
Albuminuria
1
2012
181
0.020
Why?
Brain Death
1
2011
30
0.020
Why?
Immunosuppression
1
2011
121
0.020
Why?
Adolescent
1
2019
3571
0.020
Why?
Pancreas
1
2011
104
0.020
Why?
European Continental Ancestry Group
1
2015
1180
0.020
Why?
North Carolina
1
2014
1520
0.020
Why?
Severity of Illness Index
1
2012
926
0.020
Why?
Randomized Controlled Trials as Topic
1
2011
511
0.020
Why?
Kidney
1
2012
529
0.020
Why?
Death
1
2008
48
0.020
Why?
Cryopreservation
1
2007
55
0.020
Why?
Cohort Studies
1
2011
1832
0.020
Why?
Risk Assessment
1
2012
1447
0.020
Why?
Prospective Studies
1
2011
2274
0.020
Why?
Diabetes Mellitus, Type 2
1
2011
1428
0.010
Why?
Reeves-Daniel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (19)
Explore
_
Similar People (53)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_